mRNA Electroporated Autologous Dendritic Cells for Stage III/IV Melanoma
NCT01676779
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
88
Enrollment
OTHER
Sponsor class
Conditions
Malignant Melanoma Stage III
Malignant Melanoma Stage IV
Interventions
BIOLOGICAL:
Dendritic cell therapy
Sponsor
Universitair Ziekenhuis Brussel
Collaborators
[object Object]